Mexico: assessing the impact of the reshaped IP and regulatory framework
Introduction Mexico’s pharmaceutical and life sciences regulatory landscape has undergone significant developments throughout 2026, marking one of the most substantial regulatory shifts in recent years for the innovative sector. Recent amendments to the …